CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, L.-L.
Right arrow Articles by Cheng, A.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, L.-L.
Right arrow Articles by Cheng, A.-J.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 439-443, May 2003
© 2003 American Association for Cancer Research

The XRCC1 399Gln Polymorphism and the Frequency of p53 Mutations in Taiwanese Oral Squamous Cell Carcinomas1

Ling-Ling Hsieh2, Huei-Tzu Chien, I-How Chen, Chun-Ta Liao, Hung-Ming Wang, Shih-Ming Jung, Pei-Feng Wang, Joseph Tung-Chieh Chang, Min-Chi Chen and Ann-Joy Cheng

Departments of Public Health [L-L. H., H-T. C., P-F. W., M-C. C.] and Otolaryngology Oncology, Head and Neck Surgery [I-H. C., C-T. L.], Division of Hematology/Oncology Department of Internal Medicine [H-M. W.], and Department of Medical Technology [A-J. C.], Chang Gung University, Tao-Yuan 333, Taiwan; Departments of Pathology [S-M. J.], and Radiation Oncology [J. T-C. C.], Chang Gung Memorial Hospital, Tao-Yuan 333, Taiwan; and Taipei Chang Gung Memorial Hospital Head and Neck Oncology Group, Tao-Yuan, 333 Taiwan [L-L. H., I-H. C., C-T. L., H-M. W., S-M. J., J. T-C. C., M-C. C., A-J. C.].


   Abstract
Top
 Abstract
Introduction
 Material and Methods
 Results
 Discussion
 References
 
DNA repair gene polymorphisms have been implicated as susceptibility factors in cancer development. It is possible that DNA repair polymorphisms may also influence the risk of gene mutation. The 399Gln polymorphism in the DNA repair gene XRCC1 has been indicated to have a contributive role in DNA adduct formation, sister chromatid exchange, and an increased risk of cancer development. Two hundred thirty-seven male oral squamous cell carcinomas (OSCCs) were included in a study to investigate the role of the XRCC1 194Trp, 280His, and 399Gln polymorphisms on p53 gene mutation. PCR-single-strand conformation polymorphism and DNA sequencing were used to analyze the conserved regions of the p53 gene (exons 5–9). The XRCC1 genotype was determined by PCR-RFLP. Nineteen (8.02%) of the 237 OSCCs had a Gln/Gln genotype. One hundred six (43.88%) of the 237 OSCCs showed p53 gene mutations at exons 5–9. The OSCC patients with a Gln/Gln genotype exhibited a significantly higher frequency of p53 mutation than those with an Arg/Gln and an Arg/Arg genotype. After adjustment for age, cigarette smoking, areca quid chewing, and alcohol drinking, the Gln/Gln genotype still showed an independent association with the frequency of p53 mutation (odd ratio, 4.50; 95% confidence interval, 1.52–13.36). The findings support the hypothesis that XRCC1 Arg399Gln amino acid change may alter the phenotype of the XRCC1 protein, resulting in a DNA repair deficiency. This study also suggests an important role for the XRCC1 399Gln polymorphism in p53 gene mutation in Taiwanese OSCCs.


   Introduction
Top
 Abstract
 Introduction
Material and Methods
 Results
 Discussion
 References
 
Tobacco and alcohol are well-established risk factors for oral cancer. A dose relationship between the consumption of tobacco or alcohol or both and oral cancer has been demonstrated in the Western countries. On the basis of epidemiological studies in India, a working group of the IARC concluded that there was adequate evidence for an association between chewing AQ3 together with tobacco use (chewing or smoking) and oral cancer (1) . In Taiwan, ~80% of all oral cancer patients are associated with the AQ chewing habit (2) . In addition, most Taiwanese AQ chewers are also smokers and alcohol drinkers.

AQ is a combination of areca nut, lime, betle leaf, and tobacco. The composition of the AQ varies in different geographical locations. In Taiwan, tobacco is not included in the preparation of AQ. As an alternative, Piper betle, which is not used elsewhere except Papua New Guinea, inflorescence is added to AQ, and it contains a high concentration of safrole (3) . Safrole-DNA adducts have been detected in 77% (23 of 30) of the OSCC tissues in a study of Taiwanese oral cancer patients with an AQ chewing history (4) . Tobacco smoke contains an array of potent carcinogens including polycyclic aromatic hydrocarbons, aromatic amines, and tobacco-specific nitrosamines. These carcinogens can be metabolized in vivo and form adducts with DNA.

Previous studies have shown that certain carcinogens may induce a "fingerprint"-like pattern of mutations at the p53 gene, in terms of both mutation type and codon specificity (5) . The most striking example is the p53 mutational spectrum found in hepatocellular carcinoma from either Qidong, People’s Republic of China (6 , 7) or Southern Africa (8 , 9) . A G:C to T:A transversion at the third base position of codon 249 of the p53 gene is strongly associated with dietary aflatoxin intake and hepatitis B virus infection. This type of mutation is consistent with mutations caused in vitro by aflatoxin B1 (10 , 11) . Hence, the mutation spectrum associated with a human cancer can provide clues as to the nature of the incriminating carcinogens and the mutagenic mechanisms responsible for the genetic lesions that drive human carcinogenesis. Recently, we reported an important contributive role for tobacco carcinogens in p53 mutation for a series of Taiwanese patients with OSCCs (12) . In addition, alcohol significantly increased the frequency of p53 mutations (OR, 2.24; 95% CI, 1.21–4.15) after adjustment for cigarette smoking and AQ chewing. Garro et al. (13) and Mufti (14) have demonstrated that chronic alcohol consumption interferes with the repair of alkylated DNA. Therefore, it is possible that alcohol interferes with the repair of DNA damaged by cigarette smoking, and this increases the possibility of p53 mutations in Taiwanese OSCCs.

DNA repair enzymes monitor DNA to correct damaged nucleotide residues generated by replication or exposure to carcinogens and cytotoxic compounds. Mutations are early events in carcinogenesis (15) , and defective DNA repair is a risk factor for many types of cancer (16, 17, 18, 19) . Although DNA repair deficiencies often arise from mutations in genes that result in a functional loss of the DNA repair protein, DNA polymorphisms may alter the structure of the DNA repair enzyme and modulate repair capability. Mutations and polymorphisms have been identified in many of the genes coding for DNA repair enzymes. Among these, XRCC1 polymorphisms have been suggested as playing a role in the etiology of smoking-related squamous cell carcinoma of the head and neck (20) .

Shen et al. (21) reported five polymorphisms in the XRCC1 gene, three of which occur at conserved sequences and resulted in amino acid substitutions. These three coding polymorphisms were detected at codons 194 (Arg-Trp), 280 (Arg-His), and 399 (Arg-Gln). Among these three polymorphisms, Lunn et al. (22) reported that the 399 Arg to Gln amino acid change was associated with high levels of AFB1-DNA adducts in a group of Taiwanese maternity subjects and with increased glycophorin A NN mutations in a mixed population of smokers and nonsmokers residing in North Carolina. Recently, Abdel-Rahman and El-Zein (23) found that, although the 194Trp polymorphism did not seem to reduce DNA repair efficiency, the 399Gln polymorphism seemed to be associated with the reduced repair of NNK-induced genetic damage in cultured human lymphocytes. In this study, we test whether the XRCC1 194Trp, 280His, or 399Gln polymorphisms are associated with an increased frequency of p53 mutations in Taiwanese OSCCs.


   Material and Methods
Top
 Abstract
 Introduction
 Material and Methods
Results
 Discussion
 References
 
Study Subjects.
Two hundred sixty-four oral cancer patients were enrolled from Chang Gung Memorial Hospital, Lin-Kuo, between March 1999 and September 2000. All of the cases were histologically confirmed. Female patients (n = 17) were excluded from this study because of an insufficient number. Those who were diagnosed as non-squamous cell carcinoma (n = 10) were also excluded. Thus, a total of 237 male OSCC patients, including 187 patients previously studied (12) , were included for the present analysis. After informed consent was obtained, 10 ml of blood were drawn into heparinized tubes (Vacutainer). The whole blood was separated into plasma, buffy coat cells, and red blood cells by centrifugation within 24 h of obtaining the blood, then stored in a -70°C freezer. Genomic DNA for genotyping was extracted and purified from the buffy coat cells as described previously (24) .

Surgically removed samples were sent to the Department of Pathology, Chang Gung Medical Center, for examination and were scored according to the recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms by the Associations of Directors of Anatomic and Surgical Pathology (25) . Histology diagnosis was defined as squamous cell carcinoma, verrucous carcinoma, cylindric cell carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, and adenocarcinoma.

Tobacco, AQ, and Alcohol Use.
All of the patients were interviewed uniformly before surgery by a well-trained interviewer. Study participants were asked whether they had ever smoked cigarettes, chewed AQ, or drunk alcohol on a regular basis (at least once a week). Those who responded "yes" to these questions were classified as tobacco, AQ, and alcohol users.

Mutation Analysis of the p53 Gene.
Mutation analysis of the p53 gene was performed as described previously (12) . Briefly, SSCP analysis was used to analyze tumor samples for mutations within exons 5–9 of the p53 gene, which are the regions most frequently affected by mutations in human tumors. Cases displaying an altered electrophoretic mobility were reamplified in another reaction and were analyzed by direct sequencing of both strands to confirm and characterize the nature of the mutation.

Genotyping.
XRCC1 genotypes were detected using a PCR-RFLP technique as described by Lunn et al. (22) . For codon 194 and 399, PCR was performed in a 25-µl mixture containing 100 ng of genomic DNA, 1.5 mM MgCl2, 300 µM each dNTPs, 1 unit of Taq, and 100 ng of each primer in 1 x PCR buffer using the running conditions: 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min. The PCR products were digested overnight with MspI at 37°C, electrophoresed in 6% polyacrylamide gels, stained with ethidium bromide, and photographed under UV light. For codon 280 polymorphism, a separate PCR was performed in a 25-µl mixture containing 100 ng of genomic DNA, 1.5 mM MgCl2, 200 µM each dNTPs, 2 units of Taq, and 100 ng of each primer in 1 x PCR buffer using the running conditions: 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min. The PCR products were digested overnight with RsaI at 37°C, electrophoresed in 6% polyacrylamide gels, stained with ethidium bromide, and photographed under UV light.

Statistical Analysis.
Statistical Analysis System (SAS) version 8.1 and EGRET were used for the statistical analysis. The association between XRCC1 genotype and cigarette smoking, alcohol drinking, AQ chewing, and the frequency of p53 mutation was examined by the {chi}2 test. Logistic regression with an adjustment for age, cigarette smoking, alcohol drinking, and AQ chewing was used to estimate the OR and the 95% CI for the XRCC1 genotype. The interactions between XRCC1 399 genotype and cigarette smoking, alcohol drinking, or AQ chewing on the frequency of p53 mutation were also tested in the multiple logistic regression model.


   Results
Top
 Abstract
 Introduction
 Material and Methods
 Results
Discussion
 References
 
Two hundred thirty-seven consecutive patients with a diagnosis of OSCC were enrolled in the study. The demographic data of the patients is shown in Table 1Citation . The most common primary sites were the bucca and the tongue. Ninety % (210 of 233) of the patients had smoked at some time, 57.26% (134 of 234) were users of alcohol at some time, and 81.20% (190 of 234) had chewed AQ at some time.


View this table:
[in this window]
[in a new window]
  		Table 1 Characteristics of the male patients with OSCCs (n = 237)

 
The frequency of the 194Trp, 280His, and 399Gln allele was 0.30, 0.11, and 0.28, respectively. The frequency of the Trp/Trp, Trp/Arg, and Arg/Arg genotypes for codon 194 was 9.91, 40.09, and 50.00%, respectively. The frequency of the His/His, His/Arg, and Arg/Arg genotypes for codon 280 was 1.30, 19.13, and 79.57%, respectively. The frequency of the Gln/Gln, Gln/Arg, and Arg/Arg of codon 399 was 8.02, 39.66, and 52.32%, respectively. All of the distributions were in Hardy-Weinberg equilibrium. After stratifying for smoking, alcohol drinking, and AQ chewing, no differences in genotype frequencies were noted between subgroups of patients (data not shown). Furthermore, the distribution of all three of the polymorphisms was not associated with age, tumor TNM stage, and primary site.

Tumor samples from these 237 OSCC patients, including 187 samples published previously (12) , were examined for mutations within exons 5–9 of the p53 gene by PCR-SSCP. One hundred four (43.88%) of the 237 OSCCs showed p53 gene mutations at exons 5–9. The frequency of p53 mutations was not associated with age, TNM stage, cigarette smoking, or AQ chewing. However, alcohol drinkers had a significantly higher frequency (67 of 134, 50.00%) of p53 mutations than nonusers of alcohol (34 of 100, 34.00%; P = 0.01).

Individuals with the 399 Gln/Gln genotype were more likely to have p53 gene mutations OR, 4.29; 95% CI, 1.45–12.66; Table 2Citation ) than those with the 399 Arg/Arg genotype. After adjustment for age, cigarette smoking, alcohol drinking, and AQ chewing, individuals with 399 Gln/Gln genotype still had a higher frequency of p53 mutations (OR, 5.03; 95% CI, 1.60–15.83) than those with the 399 Arg/Arg genotype. The adjusted OR of the 399 Gln/Arg heterozygous individuals was only slightly higher than that of individuals with the 399 Arg/Arg genotype (OR, 1.08; 95% CI, 0.61–1.89). After dichotomizing the data for the XRCC1 399 Gln/Gln genotype versus the Gln/Arg and Arg/Arg genotypes, the OR for the 399 Gln/Gln being associated with the frequency of p53 gene mutation was 3.98 (95% CI, 1.39–11.45). After adjustment for age, cigarette smoking, alcohol drinking, and AQ chewing, the 399 Gln/Gln genotype still showed an independent association with the frequency of p53 mutation (OR, 4.50; 95% CI, 1.52–13.36). No statistically significant association was observed between the frequency of p53 gene mutation and the 194 Trp/Trp or 280 His/His genotypes.


View this table:
[in this window]
[in a new window]
  		Table 2 The association of p53 gene mutations and XRCC1 genotypes

 
Table 3Citation shows that alcohol drinkers have a higher frequency of p53 mutations despite their XRCC1 codon 399 genotype after eliminating the interaction effect. Regardless of the cigarette smoking, alcohol consumption, and AQ chewing status of the individuals with 399 Gln/Gln genotype, they had a higher frequency of p53 gene mutation than individuals with Gln/Arg or Arg/Arg genotypes. Because the sample sizes were small in the groups with 399 Gln/Gln genotype, the nonsignificant ORs that 95% CI covers should require further confirmation when more subjects are recruited. The interactions between XRCC1 399 genotype and cigarette smoking, alcohol drinking, or AQ chewing on the frequency of p53 mutation were also tested in the multiple logistic regression model. However, the interactions were not statistically significant.


View this table:
[in this window]
[in a new window]
  		Table 3 Stratification analysis of the XRCC1 399 genotype and the frequency of p53 gene mutation

 

   Discussion
Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
References
 
Recently, we reported that tobacco carcinogens play an important contributory role with respect to the p53 mutation in Taiwanese OSCCs (12) . In addition, the most prevalent types of p53 mutation found in Taiwanese OSCCs were G:C to A:T transitions, and G:C to T:A transversions. G:C to A:T transitions are the most common mutations observed in lung adenocarcinoma in rodents treated with NNK (26 , 27) and in hamster buccal pouch carcinomas induced by N-methyl-N-benzyl-nitrosamine, a potent alkylating carcinogen that is similar to tobacco nitrosamine (28) . G:C to T:A transversions are attributed to NNK in experimental animal models (29) . Studies have shown that NNK increases the levels of 8-hydroxydeoxy-guanosine (8-OHdG) in DNA (30 , 31) . 8-OHdG is removed from DNA by the base excision repair pathway (32) . Furthermore, evidence from the literature also indicates that NNK-induced methylated and pyridyloxobutylated DNA adducts, in addition to being repaired by the nucleotide excision repair pathway, are also repaired by base excision repair (30) . XRCC1 plays an important role in the base excision repair pathway, and interacts with DNA polymerase ß, PARP, and DNA ligase III. It also has a BRCT domain, which is characteristic of proteins involved in cycle checkpoint functions, and this domain can be responsive to DNA damage (33 , 34) . Thus, XRCC1 enzyme may play a role in the carcinogenesis pathway of Taiwanese oral cancer.

This study demonstrated a significant association between the XRCC1 399Gln/Gln genotype and the frequency of p53 gene mutations in Taiwanese OSCCs. This finding suggests that polymorphism at XRCC1 codon 399 plays a role relative to p53 gene mutation in chemical carcinogen-associated OSCCs. Lunn et al. (22) reported that XRCC1 codon 399 polymorphism was associated with higher levels of both AFB1-DNA adducts and glycophorin A variants in a normal population. Abdel-Rahman and El-Zein (23) found that the 399Gln polymorphism appeared to be associated with the reduced repair of NNK-induced genetic damage in cultured human lymphocytes. Taken together, these findings provide evidence that the 399Gln polymorphism of the XRCC1 gene is associated with reduced DNA repair efficiency. This hypothesis is biologically plausible. In theory, amino acid changes at conserved sites may alter enzyme function. The Arg399Gln polymorphism occurs in a region of the XRCC1 gene that contains biologically important domains (the PARP binding and the BRCT domain), and these domains have homology with other DNA repair-related genes (34) .

Our previous study demonstrated that alcohol has a significant association with the frequency of p53 mutations (OR, 2.24; 95% CI, 1.21–4.15) after adjustment for cigarette smoking and AQ chewing (12) . It has been suggested that alcohol may have an effect on DNA repair mechanisms. Garro et al. (13) and Mufti (14) have demonstrated that chronic alcohol consumption interferes with the repair of alkylated DNA. In the present study, we found that alcohol drinkers have a higher frequency of p53 mutation irrespective of their XRCC1 codon 399 genotype (Table 3)Citation . Furthermore, alcohol has a significant association with the frequency of p53 mutations (OR, 2.11; 95% CI, 1.21–3.68) after adjustment for age, cigarette smoking, AQ chewing, and XRCC1 399 genotype in the present series of OSCCs. This finding supports the hypothesis that alcohol may have a significant real inhibitory effect on the DNA repair mechanisms.

Lunn et al. (22) found that individuals carrying a 194Trp allele were slightly more common in the nondetectable AFB1-DNA adduct group. Furthermore, Sturgis et al. (20) demonstrated that the 194 Arg/Arg genotype was a significant risk factor specifically for cancers of the oral cavity and pharynx (adjusted OR, 2.46; 95% CI, 1.22–4.97). However, Abdel-Rahman and El-Zein (23) found that there was no significant difference in NNK-induced sister chromatid exchange between cells with the codon 194 Arg/Arg genotype and cells with the codon 194 Arg/Trp genotype at all concentrations of NNK tested. Our present study did not observe a significant association of 194Trp with the frequency of p53 mutations. But it is interesting to note that of the 19 individuals with 399Gln/Gln genotype in this series of OSCC patients, all were also of the 194Arg/Arg genotype; and of the 111 individuals carrying 194Trp alleles, all carried the 399Arg allele. Therefore, this suggests that, in the future, a study of the association between the haplotype for this gene and DNA adduct formation, sister chromatid exchange, and risk of cancer development would be useful.

This study is limited because it analyzed only p53 mutations within exons 5–9. Soussi and Beroud (35) analyzed 158 studies that screened the entire p53 gene and found that 13.6% of mutations were located outside exons 5–8, with a significant number of mutations in exons 4, 10, and, to a lesser extent, 9. Although the frequency of p53 mutations in our series of OSCCs may be biased, this should not affect our findings, even if the XRCC1 399Gln/Gln genotype is not associated with the p53 mutations outside exons 5–9.

In conclusion, after adjustment for smoking, AQ chewing, and alcohol drinking, the XRCC1 399 Gln/Gln genotype still showed an independent association with the frequency of p53 mutations (OR, 4.50; 95% CI, 1.52–13.36). The findings support the hypothesis that XRCC1 Arg399Gln amino acid change may alter the phenotype of the XRCC1 protein, resulting in deficient DNA repair. Our study also suggests an important role for the XRCC1 399Gln polymorphism on p53 gene mutation in Taiwanese OSCCs.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by Grants NSC 89-2314-B182-096 and NSC 90-2320-B182-055 from the National Science Council and by Grants DOH88-HR-802, NHRI-GT-EX89P802P, NHRI-EX90-8802PP, and NHRI-CN-IN-9005P from the National Health Research Institute, Department of Health, The Executive Yuan, Republic of China. Back

2 To whom requests for reprints should be addressed, at Department of Public Health, Chang Gung University, 259 Wen-Hwa 1 Road, Kwei-San, Tao-Yuan 33332, Taiwan, Republic of China. Back

3 The abbreviations used are: AQ, areca quid; OSCC, oral squamous cell carcinoma; OR, odds ratio; CI, confidence interval; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; PARP, poly(ADP-ribose) polymerase; AFB1-DNA, aflatoxin B1-DNA; SSCP, single-stranded conformation polymorphism; BRCT, BRCA1 C-terminal. Back

Received 5/28/02; revised 1/16/03; accepted 1/31/03.


   References
Top
 Abstract
 Introduction
 Material and Methods
 Results
 Discussion
 References
 

  1. IARC. Betel-quid and areca-nut chewing. IARC Monogr., 37: 141-291, 1986.
  2. Ko Y. C., Huang Y. L., Lee C. H., Chen M. J., Lin L. M., Tsai C. C. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral Pathol. Med., 24: 450-453, 1995.[Medline]
  3. Hwang L. S., Wang C. K., Sheu M. J., Kao L. S. Phenolic compounds of piper betel flower as flavoring and neuronal activity modulating agents Ho C. T. Osawa T. Huang M. T. Rossen R. T. eds. . Food Phytochemicals for Cancer Prevention I., 186-191, American Chemical Society Wash. DC 1993.
  4. Chen C. L., Chi C. W., Chang K. W., Liu T. Y. Safrole-like DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history. Carcinogenesis (Lond.), 20: 2331-2334, 1999.[Abstract/Free Full Text]
  5. Hussain S. P., Harris C. C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res., 58: 4023-4037, 1998.[Free Full Text]
  6. Hsu I. C., Metcalf R. A., Sun T., Welsh J., Wang N. J., Harris C. C. p53 gene mutational hotspot in human hepatocellular carcinomas from Qidong, China. Nature (Lond.), 350: 427-428, 1991.[Medline]
  7. Scorsone K. A., Zhou Y. Z., Butel J. S., Slagle B. L. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res., 52: 1635-1638, 1992.[Abstract/Free Full Text]
  8. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.[Medline]
  9. Ozturk M., Collaborators. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338: 1356-1359, 1991.[Medline]
  10. Aguilar F., Hussain S. P., Cerutti P. Aflatoxin B1 induces the transversion of G -> T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl. Acad. Sci. USA, 90: 8586-8590, 1993.[Abstract/Free Full Text]
  11. Mace K., Aguilar F., Wang J. S., Vautravers P., Gomez-Lechon M., Gonzalez F. J., Groopman J., Harris C. C., Pfeifer A. M. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis (Lond.), 18: 1291-1297, 1997.[Abstract/Free Full Text]
  12. Hsieh L. L., Wang P. F., Chen I. H., Liao C. T., Wang H. M., Chen M. C., Chang J. T. C., Cheng A. J. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis (Lond.), 22: 1497-1503, 2001.[Abstract/Free Full Text]
  13. Garro A. J., Espina N., Farinati F., Salvagnini M. The effects of chronic ethanol consumption on carcinogen metabolism and on O6-methylguanine transferase-mediated repair of alkylated DNA. Alcoholism Clin. Exp. Res., 10 (Suppl.): 73S-77S, 1986.[Medline]
  14. Mufti S. I. Alcohol acts to promote incidence of tumors. Cancer Detect. Prev., 16: 157-162, 1992.[Medline]
  15. Loeb K. R., Loeb L. A. Significance of multiple mutations in cancer. Carcinogenesis (Lond.), 21: 379-385, 2000.[Abstract/Free Full Text]
  16. Rajewsky M. F., Engelbergs J., Thomale J., Schweer T. Relevance of DNA repair to carcinogenesis and cancer therapy. Recent Results Cancer Res., 154: 127-146, 1998.[Medline]
  17. Millar A. L., Pal T., Madlensky L., Sherman C., Temple L., Mitri A., Cheng H., Marcus V., Gallinger S., Redston M., Bapat B., Narod S. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium. Hum. Mol. Genet., 8: 823-829, 1999.[Abstract/Free Full Text]
  18. Yao X., Buermeyer A. B., Narayanan L., Tran D., Baker S. M., Prolla T. A., Glazer P. M., Liskay R. M., Arnheim N. Different mutator phenotypes in Mlh1-versus Pms2-deficient mice. Proc. Natl. Acad. Sci. USA, 96: 6850-6855, 1999.[Abstract/Free Full Text]
  19. Benhamou S., Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat. Res., 462: 149-158, 2000.[Medline]
  20. Sturgis E. M., Castillo E. J., Li L., Zheng R., Eicher S. A., Clayman G. L., Strom S. S., Spitz M. R., Wei Q. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis (Lond.), 20: 2125-2129, 1999.[Abstract/Free Full Text]
  21. Shen M. R., Jones I. M., Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res., 58: 604-608, 1998.[Abstract/Free Full Text]
  22. Lunn R. M., Langlois R. G., Hsieh L. L., Thompson C. L., Bell D. A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res., 59: 2557-2561, 1999.[Abstract/Free Full Text]
  23. Abdel-Rahman S. Z., El-Zein R. A. The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett., 159: 63-71, 2000.[Medline]
  24. Hsieh L. L., Liou S. H., Chen Y. H., Tsai L. C., Yang T., Wu T. N. Association between aminolevulinate dehydrogenase genotype and blood lead levels in Taiwan. J. Occup. Environ. Med., 42: 151-155, 2000.[Medline]
  25. Association of Directors of Anatomic and Surgical Pathology Recommendations for the reporting of specimens containing oral cavity and oropharynx neoplasms. Mod. Pathol., 13: 1038-1041, 2000.[Medline]
  26. Belinsky S. A., Devereux T. R., White C. M., Foley J. F., Maronpot R. R., Anderson M. W. Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. Exp. Lung Res., 17: 263-278, 1991.[Medline]
  27. Oreffo V. I., Lin H. W., Padmanabhan R., Witschi H. K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. Carcinogenesis (Lond.), 14: 451-455, 1993.[Abstract/Free Full Text]
  28. Chang K. W., Lin S. C., Koos S., Pather K., Solt D. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis (Lond.), 17: 595-600, 1996.[Abstract/Free Full Text]
  29. Ronai Z. A., Gradia S., Peterson L. A., Hecht S. S. G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis (Lond.), 14: 2419-2422, 1993.[Abstract/Free Full Text]
  30. Cloutier J. F., Castonguay A. Modulation of DNA repair by various inhibitors of DNA synthesis following 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced DNA damage. Chem. Biol. Interact., 110: 7-25, 1998.[Medline]
  31. Hecht S. S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat. Res., 424: 127-142, 1999.[Medline]
  32. Salles B., Sattler U., Bozzato C., Calsou P. Repair of oxidative DNA damage in vitro: a tool for screening antioxidative compounds. Food Chem. Toxicol., 37: 1009-1014, 1999.[Medline]
  33. Caldecott K. W., Aoufouchi S., Johnson P., Shall S. XRCC1 polypeptide interacts with DNA polymerase ß and possibly poly(ADP-ribose) polymerase, and DNA ligase III is a novel molecular ‘nick-sensor’ in vitro.. Nucleic Acids Res., 24: 4387-4394, 1996.[Abstract/Free Full Text]
  34. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol., 18: 3563-3571, 1998.[Abstract/Free Full Text]
  35. Soussi T., Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer, 1: 233-240, 2001.[Medline]



This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Majumder, N. Sikdar, R. R. Paul, and B. Roy
Increased Risk of Oral Leukoplakia and Cancer Among Mixed Tobacco Users Carrying XRCC1 Variant Haplotypes and Cancer Among Smokers Carrying Two Risk Genotypes: One on Each of Two Loci, GSTM3 and XRCC1 (Codon 280)
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2106 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Z. Hu, H. Ma, F. Chen, Q. Wei, and H. Shen
XRCC1 Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control Studies
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1810 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L.-E Wang, M. L. Bondy, H. Shen, R. El-Zein, K. Aldape, Y. Cao, V. Pudavalli, V. A. Levin, W. K. A. Yung, and Q. Wei
Polymorphisms of DNA Repair Genes and Risk of Glioma
Cancer Res., August 15, 2004; 64(16): 5560 - 5563.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. C. Figueiredo, J. A. Knight, L. Briollais, I. L. Andrulis, and H. Ozcelik
Polymorphisms XRCC1-R399Q and XRCC3-T241M and the Risk of Breast Cancer at the Ontario Site of the Breast Cancer Family Registry
Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 583 - 591.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsieh, L.-L.
Right arrow Articles by Cheng, A.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsieh, L.-L.
Right arrow Articles by Cheng, A.-J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online